# Brain Networks and Addiction Susceptibility

> **NCT01924468** · PHASE1 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 76 (actual)

## Conditions studied

- Nicotine Dependence

## Interventions

- **DRUG:** Oral methylphenidate and Oral haloperidol

## Key facts

- **NCT ID:** NCT01924468
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08-14
- **Primary completion:** 2018-09-05
- **Final completion:** 2019-05-14
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2019-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01924468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01924468, "Brain Networks and Addiction Susceptibility". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01924468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*